BIOLARGO, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Biolargo, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Biolargo, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 301M shares, a 4.03% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 301M +11.7M +4.03% Nov 12, 2024 10-Q 2024-11-14
Q2 2024 301M +12.5M +4.36% Aug 13, 2024 10-Q 2024-08-14
Q1 2024 296M +12.4M +4.37% Mar 29, 2024 10-K 2024-04-01
Q3 2023 290M +14.1M +5.11% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 288M +18.6M +6.92% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 283M +20.5M +7.79% Mar 29, 2023 10-K 2023-03-31
Q3 2022 275M +17.7M +6.86% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 269M +41.3M +18.1% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 263M +23.9M +10% Mar 30, 2022 10-K 2022-03-31
Q3 2021 258M +35.3M +15.9% Nov 11, 2021 10-Q 2021-11-15
Q2 2021 228M +14.6M +6.83% Aug 10, 2021 10-Q 2021-08-16
Q1 2021 239M +66.4M +38.6% Mar 24, 2021 10-K 2021-03-30
Q3 2020 222M +58.5M +35.7% Nov 13, 2020 10-Q 2020-11-16
Q2 2020 214M +56.2M +35.7% Aug 10, 2020 10-Q 2020-08-14
Q1 2020 172M +29.2M +20.4% Mar 26, 2020 10-K 2020-03-31
Q3 2019 164M +31.6M +23.9% Nov 8, 2019 10-Q 2019-11-14
Q2 2019 157M +26.8M +20.6% Aug 12, 2019 10-Q 2019-08-14
Q1 2019 143M +38M +36.1% Mar 20, 2019 10-K 2019-03-29
Q3 2018 132M +29.9M +29.2% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 131M +30M +29.8% Aug 10, 2018 10-Q 2018-08-14
Q1 2018 105M +10.2M +10.7% Mar 13, 2018 10-K 2018-03-16
Q3 2017 102M +12.4M +13.8% Nov 12, 2017 10-Q 2017-11-14
Q2 2017 101M +13.5M +15.5% Aug 11, 2017 10-Q 2017-08-14
Q1 2017 94.9M +8.67M +10.1% Mar 30, 2017 10-K 2017-03-30
Q3 2016 89.9M +4.13M +4.81% Nov 10, 2016 10-Q 2016-11-14
Q2 2016 87.1M +2.61M +3.09% Aug 4, 2016 10-Q 2016-08-15
Q1 2016 86.3M +3.27M +3.94% Mar 29, 2016 10-K 2016-03-30
Q3 2015 85.8M +3.71M +4.52% Nov 13, 2015 10-Q 2015-11-16
Q2 2015 84.5M +3.51M +4.34% Aug 6, 2015 10-Q 2015-08-10
Q1 2015 83M +3.16M +3.96% Mar 28, 2015 10-K 2015-03-31
Q3 2014 82.1M +7.6M +10.2% Nov 11, 2014 10-Q 2014-11-14
Q2 2014 81M +7.81M +10.7% Aug 12, 2014 10-Q 2014-08-15
Q1 2014 79.8M +7.76M +10.8% Mar 31, 2014 10-K 2014-04-01
Q3 2013 74.5M +7.89M +11.8% Nov 13, 2013 10-Q 2013-11-13
Q2 2013 73.2M +8.09M +12.4% Aug 12, 2013 10-Q 2013-08-14
Q1 2013 72.1M +11.4M +18.8% Mar 28, 2013 10-K 2013-03-29
Q3 2012 66.6M +8.26M +14.2% Nov 12, 2012 10-Q 2012-11-14
Q2 2012 65.1M +9.14M +16.3% Aug 10, 2012 10-Q 2012-08-14
Q1 2012 60.7M Apr 4, 2012 10-K 2012-04-06
Q3 2011 58.3M Nov 11, 2011 10-Q 2011-11-15
Q2 2011 55.9M Aug 1, 2011 10-Q/A 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.